The stock of NeoPhotonics (NYSE: NPTN) has been allotted an increased rating of ‘buy’ from ‘neutral’ along with a price objective of $15 from the analysts of DA Davidson on 9th March, Tuesday. This indicates a 78.57% potential upside from the present price of the firm.
On Tuesday, the company started from $8.40 with the market cap being $426.57 million. Their lowest in 12 months is $4.65 while the highest is $14.14. Their current, quick, and leverage ratio is 2.36, 1.93, and 0.18. Their 50 days rolling average is at $11.62 while the 200 day is at $8.61.
According to their 25th February report, their quarterly EPS earnings was $0.14 that topped the $0.23 consensus estimate by nearly $0.09. They had a 2.26% net margin along with a 10.55% equity return. Research analysts expect NeoPhotonics to release an EPS of 0.04 for this ongoing year.
NPTN Stock Ventures
B. Riley raised their price objective for NPTN shares to $12 from $10 and gave a rating of ‘buy’. TheStreet upgraded it to ‘b-’ from ‘c’. Piper Sandler reassigned a rating of ‘neutral’ and gave it $13. Rosenblatt Securities demoted it to $12 from $14 and gave a rating of ‘neutral’. Northland Securities reallotted a rating ‘buy’ and gave it $18. The company has a consensus ‘hold’ rating with a $12.06 price objective.
Marshall Wace raised its holdings on NPTN stock by roughly 4,963% and owns $95,000 worth of shares. Winton Group bought a new stake, owning $351,000 worth of shares. BNP Paribas upgraded their position by almost 250.5%, owning shares priced at $91,000. The Retirement System of Public Employees of Canada promoted their stake by approximately 2.9% and own shares priced at $706,000. GSA Cap. Partners lifted their position by nearly 58.2% and own $252,000 worth of shares. 80.93% NeoPhotonics stock is owned by institutional investors.
